Patent details

Basic Information

Publication number:

EP2433643

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111942579

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Medicaments comprising botulinum toxin for use in treating exacerbation of headache in medication overusers

French Title of Invention:

Médicaments comprenant de la toxine botulinique pour utilisation dans le traitement du mal de tête exacerbé par 'utilisation excessive de médicaments

German Title of Invention:

Medikamente, Botulinumtoxin enthaltend, zur Anwendung in der Behandlung von Kopfschmerzverschlimmerung bei übermässigem Gebrauch von Schmerzmitteln

SPC Number:

Dates

Filing date:

15/02/2005

Grant date:

02/12/2015

EP Publication Date:

02/12/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/03/2012

EP B1 Publication Date:

02/12/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/02/2016

Expiration date:

15/02/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/02/2005

 

 

Name:

ALLERGAN INC.

Address:

2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:

Brin Mitchell F.

Address:

United States (US)

2

Name:

Turkel Catherine C.

Address:

United States (US)

Priority

1

Priority Number:

789180

Priority Date:

26/02/2004

Priority Country:

United States (US)

2

Priority Number:

39506

Priority Date:

18/01/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/48;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages